- 2.7k Downloads
Henoch–Schönlein purpura (HSP) is the most common vasculitis of childhood. In this review, the main clinical features and complications are described. Although most features are self-limiting, renal disease is the most likely to result in long-term morbidity. Treatment of HSP nephritis is controversial, and the evidence for both prevention and treatment of established disease is reviewed. Follow-up for children presenting with HSP should be for at least 6 months and should include regular urine testing for proteinuria and haematuria and a blood pressure measurement. Women with a history of HSP during childhood are at increased risk of complications (such as proteinuria and hypertension) during pregnancy and should be monitored closely. This paper describes current practice with regard to investigation and management and proposes a practical care pathway of the management of a child with HSP.
KeywordsPurpura IgA Glomerulonephritis Intussusception Corticosteroids Treatment
Conflict of interest
The authors declare that they have no conflict of interest.
- 11.Dudley J, Smith G, Llewellyn-Edwards A, Tizard E (2007) Randomised placebo controlled trial to assess the role of early prednisolone on the development and progression of Henoch–Schönlein purpura nephritis. Pediatr Nephrol 22:1457 (abst 270)Google Scholar
- 16.Heberden W (1802) Commentaries on the history and cure of disease chapter 78: De purpueis maculis. Payne, LondonGoogle Scholar
- 17.Henoch EH (1889) Lectures on children’s diseases. A handbook for practitioners and students. New Sydenham Society, LondonGoogle Scholar
- 20.Lewis M, Shaw J, Reid C et al (2006) Demography and management of childhood established renal failure in the UK. In UK Renal Registry. The Ninth Annual Report, pp 227–241Google Scholar
- 31.Ronkainen J, Ala-Houhala M, Antikainen M et al (2006) Cyclosporine A versus Methylprednisolone pulses in the treatment of severe Henoch–Schönlein Nephritis. Pediatr Nephrol 21(10):1531Google Scholar